Drawing for ZYMENEX

USPTO serial 79026127

ZYMENEX

Reviewed by CopyMark Law Group

Reg. 3275477Status 404
Filing date
Status date
Registration date
Aug 7, 2007
Examiner
BLANE, SUZANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYMENEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for medical purposes used in the field of human illnesses or deficiencies, namely porphyria illness, lysosomal enzyme deficiency diseases and non-bacterial diseases; enzymes, enzyme-inhibitors, enzyme co-factors and enzyme related preparations, all for medical purposes for the treatment of human illnesses or deficiencies, namely porphyria illness, lysosomal enzyme deficiency diseases and non-bacterial diseases; diagnostic preparations for medical purposes used in the field of human illnesses or deficiencies, namely porphyria illness, lysosomal enzyme deficiency diseases and non-bacterial diseasesSECTION 70 - CANCELLED—
009Computer software for use in database management in the fields of medicine, education and retail sales; website development software; communications software for connecting computer network users and global computer networks; downloadable electronic publications in the nature of books, magazines, periodicals and manuals in the field of medicine; electronic publications, namely books, magazines, periodicals and manuals in the field of medicine, recorded on CD-ROMs and disks; and data processorsSECTION 70 - CANCELLED—
010Surgical and medical apparatus and instruments, namely syringes and needles for medical purposes, inhalers and blood testing apparatus for use in the treatment of porphyria illness, lysosomal enzyme deficiency diseases and non-bacterial diseasesSECTION 70 - CANCELLED—
016Publications, namely books, magazines, periodicals and manuals in the fields of medicine and health; printed instructional or teaching matter in the fields of medicine and health; printed instructional material and printed treatment guides in the field of medicine and health issues; manuals concerning the installation and maintenance of computer softwareSECTION 70 - CANCELLED—
041Providing education, training courses and instruction in the fields of medicine and information technology (IT)SECTION 70 - CANCELLED—
042Scientific, industrial, biotechnological and biomedical research in the field of human illnesses or deficiencies, namely porphyria illness, lysosomal enzyme deficiency diseases, non-bacterial diseases and other diseases related thereto and research concerning the medical treatment thereof; computer services, namely providing a database featuring data concerning medical analysis and treatment; designing, implementing and maintaining websites for others; computer network design and installation of computer softwareSECTION 70 - CANCELLED—
044Providing medical information; providing advice regarding personal management of medical conditions; providing advice to health professionals regarding medical conditions; providing medical information and medical counselingSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 18, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 8, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 20, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 18, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 11, 2015RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 24, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 3, 2014RFNPREFUSAL PROCESSED BY IB—
Oct 7, 2013DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 7, 2013DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 19, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 2, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 2, 2007FIMPFINAL DISPOSITION PROCESSED—
Nov 19, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 7, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 22, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2007NPUBNOTICE OF PUBLICATION—
Mar 22, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 22, 2007ALIEASSIGNED TO LIE—
Feb 26, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 17, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 16, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 16, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2007CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2006IRRHIRREGULARITY FROM IB EXAMINED BY MPU—
Sep 15, 2006RFNTREFUSAL PROCESSED BY IB—
Sep 4, 2006IRRFIRREGULARITY ON REFUSAL FROM IB—
Aug 30, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 30, 2006RFRRREFUSAL PROCESSED BY MPU—
Aug 28, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 27, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2006DOCKASSIGNED TO EXAMINER—
Aug 25, 2006NWAPNEW APPLICATION ENTERED—
Aug 24, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance